Anthracyline-reduced sequential combination chemotherapy for younger patients with good-prognosis aggressive B-cell non-Hodgkin's lymphoma

Introduction Anthracyline-based chemotherapy is the treatment of choice for patients with aggressive B-cell non-Hodgkin's lymphoma (NHL). However, anthracyclines have been associated with long-term cardiac toxicity. Methods We conducted a study using a sequential combination chemotherapy with a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cancer research and clinical oncology 2009-03, Vol.135 (3), p.459-466
Hauptverfasser: Schütt, P, Zimmermann, K, Derks, C, Ebeling, P, Welt, A, Poser, M, Hense, J, Metz, K, Anhuf, J, Sandmann, M, Neise, M, Moritz, T, Stuschke, M, Niederle, N, Seeber, S, Nowrousian, Mohammad R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!